|
---|
As Of | Filer | Filing¹ | For·On·As | Docs:Size | Issuer | | Filing Agent | | | | | | | | | |
---|
|
---|
6/21/06 Acer Therapeutics Inc. 8-K:4 6/15/06 1:20K Business Wire/FA
6/19/06 McWilliams David 4 Dir.,Off.² 1:7K Acer Therapeutics Inc. Rouse William
6/19/06 Rouse William 4 Officer² 1:9K Acer Therapeutics Inc.
6/19/06 Frison Paul 4 Director² 1:8K Acer Therapeutics Inc.
6/19/06 Seaman Scott B 4 Director² 1:5K Acer Therapeutics Inc. Frison Paul
6/19/06 Hung David 4 Director² 1:5K Acer Therapeutics Inc. Frison Paul
6/19/06 Bailey Gregory 4 Director² 1:5K Acer Therapeutics Inc. Frison Paul
6/19/06 Acer Therapeutics Inc. 8-K:5,8,9 6/15/06 3:22K Business Wire/FA
5/15/06 Acer Therapeutics Inc. DEF 14A 6/15/06 1:376K Business Wire/FA
____________ | ¹ | Filing/Form Types: | | 4 | Statement of Changes in Beneficial Ownership of Securities by an Insider — Form 4 { The Filer is an Insider² of the Issuer }. | | 8-K | Current Report — Form 8-K { Item 1: Business & Operations; 2: Financial Info; 3: Securities & Trading; 4: Accountants & Accounting; 5: Governance & Management; 6: Asset-Backed Securities; 7: Disclosures; 8: Events; 9: Financials }. | | DEF 14A | Definitive Proxy Statement — Schedule 14A. | ² | Insider: The Filer is a Director, Officer, 10% Owner and/or Other “insider” of the Issuer. |
|